 Obesity as determined by BMI is a confounder in clinical evaluations of the effects of endocrine disrupting chemicals . Validated regulatory tests are used to determine whether a chemical acts via a mode of action that affects estrogen androgen thyroid or steroidogenic pathways . Test batteries for evaluating EDCs include QSAR

@highlight BMI is less accurate than percent body fat.
@highlight Adipose tissue is endocrine active.
@highlight Environmental EDC exposure is low.
@highlight EDC effects are hard to measure in obese individuals.
@highlight Use percent body fat rather than BMI for EDC epidemiology.
